Profile
Stuart M.
Henderson is Chief Business Officer & Head-Investor Contact at Passage Bio, Inc. since 2024.
Former roles include VP-Corporate Development & Investor Relations at TELA Bio, Inc., Consultant at ZS Associates, Inc., and Analyst at Quaker Partners Management LP.
Education includes undergraduate studies at Cornell University.
Stuart M. Henderson active positions
| Companies | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Investor Relations Contact | 2021-01-31 |
Former positions of Stuart M. Henderson
| Companies | Position | End |
|---|---|---|
ZS Associates, Inc.
ZS Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting and technology firm | Consultant / Advisor | - |
| TELA BIO, INC. | Investor Relations Contact | - |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Private Equity Analyst | - |
Training of Stuart M. Henderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
TELA Bio, Inc.
TELA Bio, Inc. Medical SpecialtiesHealth Technology Operates as medical technology company, which designs, develops and markets tissue reinforcement materials to address unmet needs in soft tissue reconstruction | Health Technology |
ZS Associates, Inc.
ZS Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting and technology firm | Commercial Services |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Stuart M. Henderson
















